This e-learning course discusses treatment sequencing in advanced digestive neuroendocrine tumours (NETs). The course provides an overview of available treatment options and the key trials that have influenced the ENETS consensus guidelines.

Two different treatment approaches are presented after the overview of the available treatments:

  • Treatment choices for Metastatic low-grade SI-NET
  • Treatment choices for Metastatic grade 2 pNET
This course has been accredited by EACCME® for 1 ECMEC® (as detailed within the Introduction and Objectives below).

Neuroendocrine tumours (NETs) are a heterogeneous group of neoplasms whose incidence has increased significantly in recent years, and whose optimal management remains controversial. This course reviews a number of recently reported trials looking at potential treatments options with: Multiple Kinase Inhibitors, Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy (PRRT).

EACCME 認定

https://checkpoint.cor2ed.com で利用可能で、COR2ED が組織している COR2ED Checkpoint は、医療専門家に次の CME アクティビティを提供するために、European Accreditation Council for Continuing Medical Education (EACCME) の認定を受けています。

各医療専門家は、教育アクティビティを実際に行った単位のみを要求すべきです。EACCME は、European Union of Medical Specialists (UEMS) の機関です。UEMS-EACCME ウェブサイトに表示されている e-ラーニング資料のみが、公式認定を受けています。

European Union of Medical Specialists (UEMS) と American Medical Association (AMA) の間の同意を通して、医師は EACCME の単位を、同等数の AMA PRA Category 1 Credits™ に変換することができます。

EACCME 単位を AMA 単位に変換するプロセスに関する情報は www.ama-assn.org/education/earn-credit-participation-international-activities.